FOLFOXIRI Plus Cetuximab or Bevacizumab as First-Line Treatment of BRAF V600E -Mutant Metastatic Colorectal Cancer: The Randomized Phase II FIRE-4.5 (AIO KRK0116) Study.
Sebastian StinzingKathrin HeinrichDavid TougeronDominik Paul ModestIngo SchwanerJan EuckerRudolf PihuschMartina StauchFlorian KaiserChristoph A KahlMeinolf KarthausChristian MüllerChristof BurkartAnke C Reinacher-SchickStefan Kasper-VirchowLudwig Fischer von WeikersthalBeate Krammer-SteinerGerald Wolfgang PragerGilles ManceauVolker HeinemannPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
-mutant mCRC.